Showing 481 - 500 results of 597 for search '"prostate cancer"', query time: 0.07s Refine Results
  1. 481

    A case of stromal sarcoma of the prostate with the incidental detection of prostate adenocarcinoma by Shang Xu, Xinning Wang, Wei Jiao

    Published 2025-03-01
    “…Prostate stromal sarcoma is very rare among patients with prostate cancer, accounting for <0.1 % of prostate malignancy. …”
    Get full text
    Article
  2. 482

    Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation by Chang Liu, Miao Wang, Changli Xu, Bo Li, Juxiang Chen, Jianchun Chen, Zhiwei Wang

    Published 2021-01-01
    “…On this basis, we expounded the clinical application of immune checkpoint inhibitors for bone metastasis of common tumors, including non-small-cell lung cancer, renal cell carcinoma, prostate cancer, melanoma, and breast cancer. Then, the deficiencies and limitations in current researches were summarized. …”
    Get full text
    Article
  3. 483

    Primary epidemiological evaluation of the effectiveness of the All-National Dispensarization as a cancer screening by the data of the Arkhangelsk Regional Cancer Registry by L. E. Valkova, M. L. Levit, V. M. Merabishvili, A. Yu. Pankrateva, D. M. Dubovichenko, A. V. Agaeva, A. Yu. Ryzhov, E. F. Potekhina, M. Yu. Valkov

    Published 2019-12-01
    “…An increasing change of the trend of annual Stage I proportion was found in colorectal cancer since 2010, breast cancer since 2011, cervical cancer since 2013, prostate cancer since 2014, kidneys since 2006 with APC by 7.5%, 9, 6%, 9.6%, 40.3%, 13.4%, respectively.Conclusion. …”
    Get full text
    Article
  4. 484
  5. 485

    Pharmacological activities of some triazinopyrazolothieno pyrimidine derivatives by Bahashwan Saleh A.

    Published 2017-09-01
    “…Compounds 1–5 were also screened for anticancer activity on a human lung cancer cell line (A549) and a human prostate cancer cell line (DU145) using the MTT micro-cultured tetrazolium assay method. …”
    Get full text
    Article
  6. 486

    Testing Strategies for Detection of Xenotropic Murine Leukemia Virus-Related Virus Infection by Shixing Tang, Indira K. Hewlett

    Published 2011-01-01
    “…Xenotropic murine leukemia virus-related virus (XMRV) is a newly identified gamma retrovirus and may be associated with prostate cancer- (PC) and chronic fatigue syndrome (CFS). …”
    Get full text
    Article
  7. 487

    Obstructive Nephropathy from Misplaced Suprapubic Catheter with Antegrade Migration into the Urethra by Alexander W. Lipinski, Jordan R. Pollock, Nelly Tan, Douglas Rappaport

    Published 2025-01-01
    “…Case Presentation: An 83-year-old male with a history of prostate cancer and prior prostatectomy presented with lower abdominal pain, urethral leakage, and hematuria after a routine suprapubic catheter exchange, which was found to be incorrectly positioned in the bulbar urethra, leading to obstructive nephropathy with mild hydronephrosis. …”
    Get full text
    Article
  8. 488

    Residual clip after laparoscopic radical prostatectomy surgery and radiotherapy. A case report by Ismael Leblanch Hernández

    Published 2022-05-01
    “…Laparoscopic and robotic radical prostatectomy are two treatment options for prostate cancer. These procedures, although advanced, are not without risks. …”
    Get full text
    Article
  9. 489

    An Incidental Finding of Mucinous Colon Cancer by 18F-Choline PET/CT Determining a Change in Clinical Management of a Patient with Recurrent Prostate Adenocarcinoma by Carmelo Tuscano, Elvio Grazioso Russi, Said Al Sayyad, Stefano Pergolizzi

    Published 2014-01-01
    “…A 66-year-old-man underwent a PET/CT scan after a biochemical relapse for a prostate cancer previously treated with a laparoscopic surgical procedure which revealed a focal uptake in the posterior wall of sigmoid colon. …”
    Get full text
    Article
  10. 490

    Cyclooxygenase-2 Mediated Regulation of E-Cadherin Occurs in Conventional But Not Early-Onset Gastric Cancer Cell Lines by R. Sitarz, R. J. Leguit, W. W. J. de Leng, F. H. M. Morsink, W. P. Polkowski, R. Maciejewski, G. J. A. Offerhaus, A. N. Milne

    Published 2009-01-01
    “…A relationship between them is documented in non-small cell lung and prostate cancer. We present novel evidence of a relationship between COX-2 and E-cadherin expression in gastric cancer.…”
    Get full text
    Article
  11. 491

    Comparison of Robot-Assisted, Laparoscopic, and Open Radical Prostatectomy Outcomes: A Systematic Review and Network Meta-Analysis from KSER Update Series by Do Kyung Kim, Young Joon Moon, Doo Yong Chung, Hae Do Jung, Seung Hyun Jeon, Seok Ho Kang, Sunghyun Paick, Joo Yong Lee

    Published 2025-01-01
    “…Only studies of patients with prostate cancer that assessed perioperative, functional, and oncological outcomes and reported outcome values were included. …”
    Get full text
    Article
  12. 492

    Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma by Osama Diab, Dan Mcentire, Thamer Kassim, Ali Nayfeh, Abdel Rahman Dajani, Mitchell Kerfeld, Jonathon Campbell, Adbullah Alsuwaidan, Mahmoud Abu Hazeem, Maryam Gbadamosi-Akindele

    Published 2019-01-01
    “…We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. …”
    Get full text
    Article
  13. 493

    Second Suburethral Sling Implantation for the Recurrent Urinary Incontinence after Radical Prostatectomy when First Sling Surgery was Non-Effective: Case Report by Aušra Černiauskienė, Ieva Rimaitė

    Published 2023-11-01
    “…We present a case report of a 62-year-old man who underwent radical prostatectomy due to prostate cancer in 2018 and experienced moderate degree urinary incontinence. …”
    Get full text
    Article
  14. 494

    Biochemical Bone Turnover Markers and Osteoporosis in Older Men: Where Are We? by Pawel Szulc

    Published 2011-01-01
    “…In men receiving antiresorptive therapy for prostate cancer, zoledronate, denosumab and toremifene decrease significantly levels of bone resorption and bone formation markers. …”
    Get full text
    Article
  15. 495

    Near-Miss Diagnoses of Solitary Bladder Tumors Highlight the Importance of Immunohistochemical Staining by Van Schloegel, Syed M. Alam, Katie Dennis, Jeffrey Holzbeierlein, John A. Taylor III

    Published 2020-01-01
    “…Systemic therapy for prostate cancer was then initiated. These cases highlight the importance of patient history, physical exam, and IHC staining in consideration of a bladder mass, as these patients may have been subject to undue morbidity and surgical intervention without accurate pathologic diagnosis.…”
    Get full text
    Article
  16. 496

    Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report by Cynthia A. Jackevicius, Mannhu N. Ton

    Published 2009-01-01
    “…A 59-year-old man treated with warfarin for aortic valve replacement was prescribed high-dose ketoconazole and hydrocortisone for the treatment of prostate cancer. Despite lowering the warfarin dosage by 35% during the start of high dose ketoconazole, an additional dose reduction was required subsequently when the INR rose from 2.62 to 3.82 within nine days. …”
    Get full text
    Article
  17. 497

    Obesity and Cancer Screening according to Race and Gender by Heather Bittner Fagan, Richard Wender, Ronald E. Myers, Nicholas Petrelli

    Published 2011-01-01
    “…In contrast, obese/overweight men reported higher rates of prostate-specific antigen (PSA) testing. Comparison of prostate cancer screening, mammography, and Pap smears implies a gender difference in the relationship between screening behavior and weight. …”
    Get full text
    Article
  18. 498

    Sample Size Calculation for Controlling False Discovery Proportion by Shulian Shang, Qianhe Zhou, Mengling Liu, Yongzhao Shao

    Published 2012-01-01
    “…We illustrate the method using estimated correlations from a prostate cancer dataset.…”
    Get full text
    Article
  19. 499

    Peroxisome Proliferator-Activated Receptor-𝛾 Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer by Masahide Matsuyama, Rikio Yoshimura

    Published 2008-01-01
    “…In this study, we examined the expression of PPAR-𝛾 in prostate cancer (PC) and testicular cancer (TC) by RT-PCR and immunohistochemistry, and we also examined the effect of PPAR-𝛾 ligand in these cells by MTT assay, hoechest staining, and flow cytometry. …”
    Get full text
    Article
  20. 500

    The Prevalence of Climacturia in Patients after Radical Prostatectomy: A Systematic Review by João Vítor Ferrão, Alice Scalzilli Becker, Gustavo Konopka, Gustavo Bangemann, Thiago Oliboni, Nilson Marquardt Filho, Carlos Teodósio Da Ros, Gustavo Franco Carvalhal

    Published 2025-01-01
    “…ABSTRACT Purpose: Prostate Cancer (PCa) is the most common non-cutaneous cancer in males, and Radical Prostatectomy (RP) is among the primary treatments for this condition. …”
    Get full text
    Article